As far as the current situation is concerned, the new crown epidemic is still in the prevention and control stage. It can be said that it is extremely difficult to quickly eliminate the transmission route of the virus.
As the folk saying goes, "the epidemic will last only three years." The specific meaning is that even a severe epidemic can be completely ended within three years.
A medical team headed by Professor Huang Jianping (Lanzhou University) wrote a review article in a journal to predict the current epidemic trend of the new coronavirus Omicron strain.
They said that there is a high probability that the new coronavirus will end in November next year. The relevant evaluation is based on the global epidemic prediction system, which embodies the efforts of hundreds of scientific research academicians and has a monitoring accuracy of as high as 90%.
Professor Huang Jianping's team also clearly pointed out that predictions do not represent reality. After all, there are many variables in the future. If "Cheng Yaojin breaks out halfway", the epidemic may continue.
Good news comes from the medical community: my country's relevant teams have developed new coronavirus treatment drugs, which have strong ability to suppress the virus
In the middle of this month, good news comes from the medical community: Relevant medical and health teams have developed New drug designed to treat COVID-19 infection.
Currently, this new drug has been patented by the State Food and Drug Administration, and it clearly states a piece of data on the instructions: Once the concentration of stephanatine reaches 10 micromol/L, the number of times it inhibits the replication of the new coronavirus will be Over ten thousand.
In layman’s terms, if there are 15,000 new coronaviruses, and if 10 micromol/L stephanatine is used, the number of the former will drop to single digits, and the chance of infection is minimal.
According to relevant experimental data, stephanatine ranks relatively high on the list of new coronavirus inhibitory drugs. Even some Western scholars agree with its medicinal efficacy, believing that the medicinal efficacy of stephanatine has surpassed that of Parovide and Remdesivir.
Perhaps one day in the future, the health and medical team will be able to combine drugs with clinical practice to effectively curb the replication and proliferation of the new coronavirus.
Furthermore, our country is committed to researching the new crown vaccine and ensuring the safety of residents to the greatest extent. As the popularity of vaccination increases, the mortality rate of the new coronavirus will gradually decrease, and patients’ lives will no longer be threatened.